Radient Technologies Inc. Announces AGM Results
October 28 2019 - 7:30AM
Radient Technologies Inc. (“Radient” or the
“Company”) (
TSX Venture: RTI; OTCQX: RDDTF), a
global commercial manufacturer of high quality cannabinoid based
ingredients, formulations and products, today announces that all
resolutions were passed by the requisite majority at its annual
general meeting (“AGM”) held in Edmonton, Alberta, on October 25,
2019.
At the AGM, shareholders voted in favor of
setting the number of directors at nine (9) and the following
incumbent directors were re-elected: Denis Taschuk, Mike Cabigon,
Harry Kaura, Steven Dauphin, Francesco Ferlaino, Dimitris Tzanis,
Jan Petzel, Steven Splinter and Allan Cleiren. Further,
shareholders approved the Company’s stock option plan, the
Company’s Advanced Notice By-Law, the proposed amendment to the
Restated Articles of the Company, and the re-appointment of Grant
Thornton LLP as auditors of the Company for the ensuing year.
On April 17th, 2019 Radient announced it had
appointed Ms. Jocelyne F. Lafrenière and Mr. Yves Gougoux to its
Board of Directors. The Company intends to add these two new
members upon approval by Health Canada.
Following the AGM, the board of directors of
Radient re-appointed Denis Taschuk as CEO and President, Prakash
Hariharan as CFO, Mike Cabigon as COO, and Steven Splinter as
CTO.
A total of 93,703,642 common shares were
represented at the AGM, representing 34.55% of the issued and
outstanding Radient common shares. Radient would like to thank its
shareholders for their participation and continued support.
Updated Website and Investor
Materials:
On October 23rd, 2019 Radient updated its
website content to better reflect its current and future business
operations. This updated content is in line with the Company’s 2019
Annual Report, which was published in September. The Annual Report
is located in the “Investors” section of the Company’s website.
Shareholders are invited to view this document as well as the
presentation that was shown at the AGM at:
www.radientinc.com/investors.
About Radient Radient
Technologies is a commercial manufacturer of high quality
cannabinoid based formulations, ingredients and products. Utilizing
a proprietary continuous-flow extraction and processing platform
that recovers up to 99% of cannabinoids from the cannabis plant,
Radient develops specialty products and ingredients that contain a
broad range of cannabinoid and terpene profiles while meeting the
highest standards of quality and safety. Please
visit www.radientinc.com for more information.
SOURCE: Radient Technologies Inc.
Investors please contact: William (Bill) Wasson, Senior VP of
Capital Markets and Investor Relations: wwasson@radientinc.com
Media/press please contact: Caitlin Cheadle, Director of
Communications: ccheadle@radientinc.com
Forward Looking Information:
This press release contains “forward-looking information” within
the meaning of applicable Canadian securities legislation.
Forward-looking information includes, without limitation,
statements regarding the anticipated addition of Ms. Jocelyne F.
Lafrenière and Mr. Yves Gougoux to the Company’s Board of Directors
upon receipt of Health Canada approval. Generally,
forward-looking information can be identified by the use of
forward-looking terminology such as “plans”, “expects” or “does not
expect”, “is expected”, “budget”, “scheduled”, “estimates”,
“forecasts”, “intends”, “anticipates” or “does not anticipate”, or
“believes”, or variations of such words and phrases or state that
certain actions, events or results “may”, “could”, “would”, “might”
or “will be taken”, “occur” or “be achieved”. Forward-looking
information is subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of
activity, performance or achievements of Radient, as the case may
be, to be materially different from those expressed or implied by
such forward-looking information. Although Radient has attempted to
identify important factors that could cause actual results to
differ materially from those contained in forward-looking
information, there may be other factors that cause results not to
be as anticipated, estimated or intended. There can be no assurance
that such information will prove to be accurate, as actual results
and future events could differ materially from those anticipated in
such statements. Accordingly, readers should not place undue
reliance on forward-looking information. Radient does not undertake
to update any forward-looking information, except in accordance
with applicable securities laws.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS
REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE
POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Radient Technologies (TSXV:RTI)
Historical Stock Chart
From Sep 2024 to Oct 2024
Radient Technologies (TSXV:RTI)
Historical Stock Chart
From Oct 2023 to Oct 2024